nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA1B—vas deferens—testicular cancer	0.283	0.683	CbGeAlD
Phentolamine—Pain in jaw—Vinblastine—testicular cancer	0.0347	0.063	CcSEcCtD
Phentolamine—NISCH—Podofilox—Etoposide—testicular cancer	0.0193	0.539	CbGdCrCtD
Phentolamine—Swelling face—Ifosfamide—testicular cancer	0.0171	0.0311	CcSEcCtD
Phentolamine—Peptic ulcer—Vinblastine—testicular cancer	0.0169	0.0307	CcSEcCtD
Phentolamine—NISCH—Vincristine—Vinblastine—testicular cancer	0.0165	0.461	CbGdCrCtD
Phentolamine—NISCH—female gonad—testicular cancer	0.0147	0.0355	CbGeAlD
Phentolamine—SIGMAR1—seminal vesicle—testicular cancer	0.0146	0.0352	CbGeAlD
Phentolamine—Oral pain—Epirubicin—testicular cancer	0.0138	0.0251	CcSEcCtD
Phentolamine—NISCH—testis—testicular cancer	0.013	0.0315	CbGeAlD
Phentolamine—Oral pain—Doxorubicin—testicular cancer	0.0128	0.0233	CcSEcCtD
Phentolamine—ADRA2C—seminal vesicle—testicular cancer	0.0114	0.0276	CbGeAlD
Phentolamine—Tenderness—Bleomycin—testicular cancer	0.0109	0.0199	CcSEcCtD
Phentolamine—NISCH—lymph node—testicular cancer	0.00945	0.0228	CbGeAlD
Phentolamine—Tenderness—Ifosfamide—testicular cancer	0.00935	0.017	CcSEcCtD
Phentolamine—ADRA2A—seminal vesicle—testicular cancer	0.00913	0.022	CbGeAlD
Phentolamine—SIGMAR1—female gonad—testicular cancer	0.00855	0.0207	CbGeAlD
Phentolamine—Tenderness—Cisplatin—testicular cancer	0.00806	0.0146	CcSEcCtD
Phentolamine—SIGMAR1—testis—testicular cancer	0.00758	0.0183	CbGeAlD
Phentolamine—Pain—Carboplatin—testicular cancer	0.00731	0.0133	CcSEcCtD
Phentolamine—Angina pectoris—Vinblastine—testicular cancer	0.00691	0.0125	CcSEcCtD
Phentolamine—ADRA2C—female gonad—testicular cancer	0.00672	0.0162	CbGeAlD
Phentolamine—ADRA2A—gonad—testicular cancer	0.00659	0.0159	CbGeAlD
Phentolamine—Acute coronary syndrome—Vinblastine—testicular cancer	0.00623	0.0113	CcSEcCtD
Phentolamine—Myocardial infarction—Vinblastine—testicular cancer	0.0062	0.0113	CcSEcCtD
Phentolamine—ADRA2C—testis—testicular cancer	0.00596	0.0144	CbGeAlD
Phentolamine—Nasal congestion—Cisplatin—testicular cancer	0.0056	0.0102	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—testicular cancer	0.0055	0.0133	CbGeAlD
Phentolamine—ADRA2A—female gonad—testicular cancer	0.00536	0.0129	CbGeAlD
Phentolamine—Acute coronary syndrome—Bleomycin—testicular cancer	0.00526	0.00956	CcSEcCtD
Phentolamine—Myocardial infarction—Bleomycin—testicular cancer	0.00523	0.00951	CcSEcCtD
Phentolamine—Angina pectoris—Ifosfamide—testicular cancer	0.00498	0.00906	CcSEcCtD
Phentolamine—ADRA2A—testis—testicular cancer	0.00475	0.0115	CbGeAlD
Phentolamine—Orthostatic hypotension—Cisplatin—testicular cancer	0.00466	0.00847	CcSEcCtD
Phentolamine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.0045	0.00817	CcSEcCtD
Phentolamine—Myocardial infarction—Ifosfamide—testicular cancer	0.00447	0.00813	CcSEcCtD
Phentolamine—Flushing—Bleomycin—testicular cancer	0.00445	0.00808	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—testicular cancer	0.00442	0.00804	CcSEcCtD
Phentolamine—ADRA2C—lymph node—testicular cancer	0.00432	0.0104	CbGeAlD
Phentolamine—Hypertension—Vinblastine—testicular cancer	0.00426	0.00775	CcSEcCtD
Phentolamine—Bradycardia—Ifosfamide—testicular cancer	0.00417	0.00758	CcSEcCtD
Phentolamine—Flushing—Dactinomycin—testicular cancer	0.00415	0.00754	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—testicular cancer	0.00409	0.00744	CcSEcCtD
Phentolamine—Acute coronary syndrome—Cisplatin—testicular cancer	0.00388	0.00705	CcSEcCtD
Phentolamine—Myocardial infarction—Cisplatin—testicular cancer	0.00386	0.00701	CcSEcCtD
Phentolamine—Cardiac disorder—Ifosfamide—testicular cancer	0.0038	0.00691	CcSEcCtD
Phentolamine—Flushing—Ifosfamide—testicular cancer	0.0038	0.00691	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.0038	0.0069	CcSEcCtD
Phentolamine—Pain—Chlorambucil—testicular cancer	0.00376	0.00684	CcSEcCtD
Phentolamine—Angiopathy—Ifosfamide—testicular cancer	0.00372	0.00675	CcSEcCtD
Phentolamine—Mediastinal disorder—Ifosfamide—testicular cancer	0.00369	0.00671	CcSEcCtD
Phentolamine—Arrhythmia—Ifosfamide—testicular cancer	0.00366	0.00665	CcSEcCtD
Phentolamine—Paraesthesia—Vinblastine—testicular cancer	0.00362	0.00658	CcSEcCtD
Phentolamine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.0036	0.00654	CcSEcCtD
Phentolamine—Bradycardia—Cisplatin—testicular cancer	0.00359	0.00653	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—testicular cancer	0.00359	0.00652	CcSEcCtD
Phentolamine—Acute coronary syndrome—Etoposide—testicular cancer	0.00355	0.00645	CcSEcCtD
Phentolamine—Chest pain—Bleomycin—testicular cancer	0.00355	0.00645	CcSEcCtD
Phentolamine—Myocardial infarction—Etoposide—testicular cancer	0.00353	0.00642	CcSEcCtD
Phentolamine—Abdominal pain—Chlorambucil—testicular cancer	0.00348	0.00632	CcSEcCtD
Phentolamine—Pain—Vinblastine—testicular cancer	0.00345	0.00626	CcSEcCtD
Phentolamine—ADRA2A—lymph node—testicular cancer	0.00345	0.00832	CbGeAlD
Phentolamine—Injection site reaction—Doxorubicin—testicular cancer	0.00332	0.00604	CcSEcCtD
Phentolamine—Gastrointestinal pain—Vinblastine—testicular cancer	0.0033	0.00599	CcSEcCtD
Phentolamine—Cardiac disorder—Cisplatin—testicular cancer	0.00328	0.00595	CcSEcCtD
Phentolamine—Flushing—Cisplatin—testicular cancer	0.00328	0.00595	CcSEcCtD
Phentolamine—Abdominal pain—Vinblastine—testicular cancer	0.00319	0.00579	CcSEcCtD
Phentolamine—Mediastinal disorder—Cisplatin—testicular cancer	0.00318	0.00578	CcSEcCtD
Phentolamine—Hypotension—Bleomycin—testicular cancer	0.00318	0.00578	CcSEcCtD
Phentolamine—Asthenia—Chlorambucil—testicular cancer	0.00316	0.00574	CcSEcCtD
Phentolamine—Arrhythmia—Cisplatin—testicular cancer	0.00315	0.00573	CcSEcCtD
Phentolamine—Pruritus—Chlorambucil—testicular cancer	0.00311	0.00566	CcSEcCtD
Phentolamine—Hypertension—Ifosfamide—testicular cancer	0.00308	0.00559	CcSEcCtD
Phentolamine—Paraesthesia—Bleomycin—testicular cancer	0.00306	0.00556	CcSEcCtD
Phentolamine—Chest pain—Ifosfamide—testicular cancer	0.00304	0.00552	CcSEcCtD
Phentolamine—Diarrhoea—Chlorambucil—testicular cancer	0.00301	0.00547	CcSEcCtD
Phentolamine—Flushing—Etoposide—testicular cancer	0.003	0.00546	CcSEcCtD
Phentolamine—Cardiac disorder—Etoposide—testicular cancer	0.003	0.00546	CcSEcCtD
Phentolamine—Angiopathy—Etoposide—testicular cancer	0.00293	0.00533	CcSEcCtD
Phentolamine—Mediastinal disorder—Etoposide—testicular cancer	0.00292	0.0053	CcSEcCtD
Phentolamine—Pain—Bleomycin—testicular cancer	0.00291	0.00529	CcSEcCtD
Phentolamine—Asthenia—Vinblastine—testicular cancer	0.00289	0.00526	CcSEcCtD
Phentolamine—Nervous system disorder—Ifosfamide—testicular cancer	0.00285	0.00519	CcSEcCtD
Phentolamine—Vomiting—Chlorambucil—testicular cancer	0.0028	0.00508	CcSEcCtD
Phentolamine—Diarrhoea—Vinblastine—testicular cancer	0.00276	0.00501	CcSEcCtD
Phentolamine—Hypotension—Ifosfamide—testicular cancer	0.00272	0.00494	CcSEcCtD
Phentolamine—Pain—Dactinomycin—testicular cancer	0.00272	0.00493	CcSEcCtD
Phentolamine—Dizziness—Vinblastine—testicular cancer	0.00267	0.00484	CcSEcCtD
Phentolamine—Nausea—Chlorambucil—testicular cancer	0.00261	0.00475	CcSEcCtD
Phentolamine—Paraesthesia—Ifosfamide—testicular cancer	0.00261	0.00475	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.0026	0.00472	CcSEcCtD
Phentolamine—Vomiting—Vinblastine—testicular cancer	0.00256	0.00466	CcSEcCtD
Phentolamine—Headache—Vinblastine—testicular cancer	0.00253	0.00459	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00251	0.00456	CcSEcCtD
Phentolamine—Abdominal pain—Dactinomycin—testicular cancer	0.00251	0.00456	CcSEcCtD
Phentolamine—Pain—Ifosfamide—testicular cancer	0.00249	0.00452	CcSEcCtD
Phentolamine—Nervous system disorder—Cisplatin—testicular cancer	0.00246	0.00447	CcSEcCtD
Phentolamine—Tachycardia—Cisplatin—testicular cancer	0.00245	0.00445	CcSEcCtD
Phentolamine—Asthenia—Bleomycin—testicular cancer	0.00244	0.00444	CcSEcCtD
Phentolamine—Hypertension—Etoposide—testicular cancer	0.00243	0.00442	CcSEcCtD
Phentolamine—Pruritus—Bleomycin—testicular cancer	0.00241	0.00438	CcSEcCtD
Phentolamine—Chest pain—Etoposide—testicular cancer	0.0024	0.00436	CcSEcCtD
Phentolamine—Nausea—Vinblastine—testicular cancer	0.00239	0.00435	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—testicular cancer	0.00239	0.00435	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—testicular cancer	0.00239	0.00435	CcSEcCtD
Phentolamine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00238	0.00432	CcSEcCtD
Phentolamine—Hypotension—Cisplatin—testicular cancer	0.00234	0.00426	CcSEcCtD
Phentolamine—Abdominal pain—Ifosfamide—testicular cancer	0.0023	0.00418	CcSEcCtD
Phentolamine—Asthenia—Dactinomycin—testicular cancer	0.00228	0.00414	CcSEcCtD
Phentolamine—Paraesthesia—Cisplatin—testicular cancer	0.00225	0.00409	CcSEcCtD
Phentolamine—Tachycardia—Etoposide—testicular cancer	0.00224	0.00408	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00222	0.00402	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00222	0.00402	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—testicular cancer	0.00221	0.00401	CcSEcCtD
Phentolamine—Diarrhoea—Dactinomycin—testicular cancer	0.00217	0.00395	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00217	0.00394	CcSEcCtD
Phentolamine—Vomiting—Bleomycin—testicular cancer	0.00216	0.00393	CcSEcCtD
Phentolamine—Hypotension—Etoposide—testicular cancer	0.00215	0.0039	CcSEcCtD
Phentolamine—Pain—Cisplatin—testicular cancer	0.00215	0.0039	CcSEcCtD
Phentolamine—Asthenia—Ifosfamide—testicular cancer	0.00209	0.00379	CcSEcCtD
Phentolamine—Paraesthesia—Etoposide—testicular cancer	0.00206	0.00375	CcSEcCtD
Phentolamine—Pruritus—Ifosfamide—testicular cancer	0.00206	0.00374	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—testicular cancer	0.00204	0.00371	CcSEcCtD
Phentolamine—Nausea—Bleomycin—testicular cancer	0.00202	0.00367	CcSEcCtD
Phentolamine—Vomiting—Dactinomycin—testicular cancer	0.00202	0.00367	CcSEcCtD
Phentolamine—Diarrhoea—Ifosfamide—testicular cancer	0.00199	0.00362	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00198	0.00361	CcSEcCtD
Phentolamine—Pain—Etoposide—testicular cancer	0.00197	0.00357	CcSEcCtD
Phentolamine—Dizziness—Ifosfamide—testicular cancer	0.00192	0.0035	CcSEcCtD
Phentolamine—Nausea—Dactinomycin—testicular cancer	0.00189	0.00343	CcSEcCtD
Phentolamine—Gastrointestinal pain—Etoposide—testicular cancer	0.00188	0.00341	CcSEcCtD
Phentolamine—Vomiting—Ifosfamide—testicular cancer	0.00185	0.00336	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—testicular cancer	0.00185	0.00335	CcSEcCtD
Phentolamine—Abdominal pain—Etoposide—testicular cancer	0.00182	0.0033	CcSEcCtD
Phentolamine—Asthenia—Cisplatin—testicular cancer	0.0018	0.00327	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—testicular cancer	0.0018	0.00327	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—testicular cancer	0.00176	0.00319	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—testicular cancer	0.00175	0.00317	CcSEcCtD
Phentolamine—Nausea—Ifosfamide—testicular cancer	0.00173	0.00314	CcSEcCtD
Phentolamine—Diarrhoea—Cisplatin—testicular cancer	0.00172	0.00312	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—testicular cancer	0.00171	0.0031	CcSEcCtD
Phentolamine—Flushing—Epirubicin—testicular cancer	0.00168	0.00306	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—testicular cancer	0.00168	0.00306	CcSEcCtD
Phentolamine—Asthenia—Etoposide—testicular cancer	0.00165	0.003	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—testicular cancer	0.00165	0.00299	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—testicular cancer	0.00163	0.00297	CcSEcCtD
Phentolamine—Pruritus—Etoposide—testicular cancer	0.00163	0.00295	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—testicular cancer	0.00162	0.00294	CcSEcCtD
Phentolamine—Vomiting—Cisplatin—testicular cancer	0.0016	0.0029	CcSEcCtD
Phentolamine—Diarrhoea—Etoposide—testicular cancer	0.00157	0.00286	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—testicular cancer	0.00156	0.00283	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—testicular cancer	0.00156	0.00283	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—testicular cancer	0.00152	0.00277	CcSEcCtD
Phentolamine—Dizziness—Etoposide—testicular cancer	0.00152	0.00276	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—testicular cancer	0.00151	0.00275	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—testicular cancer	0.0015	0.00272	CcSEcCtD
Phentolamine—Nausea—Cisplatin—testicular cancer	0.00149	0.00271	CcSEcCtD
Phentolamine—Vomiting—Etoposide—testicular cancer	0.00146	0.00266	CcSEcCtD
Phentolamine—Headache—Etoposide—testicular cancer	0.00144	0.00262	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—testicular cancer	0.00144	0.00261	CcSEcCtD
Phentolamine—Nausea—Etoposide—testicular cancer	0.00137	0.00248	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—testicular cancer	0.00136	0.00248	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—testicular cancer	0.00135	0.00245	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—testicular cancer	0.00134	0.00244	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—testicular cancer	0.00129	0.00234	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—testicular cancer	0.00126	0.0023	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—testicular cancer	0.00126	0.00229	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—testicular cancer	0.00126	0.00228	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—testicular cancer	0.00124	0.00226	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—testicular cancer	0.00124	0.00225	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—testicular cancer	0.0012	0.00219	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00119	0.00216	CcSEcCtD
Phentolamine—Pain—Methotrexate—testicular cancer	0.00118	0.00214	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—testicular cancer	0.00117	0.00212	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—testicular cancer	0.00116	0.00211	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—testicular cancer	0.00116	0.0021	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00113	0.00205	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—testicular cancer	0.00111	0.00202	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00111	0.00202	CcSEcCtD
Phentolamine—Pain—Epirubicin—testicular cancer	0.0011	0.002	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—testicular cancer	0.00109	0.00198	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—testicular cancer	0.00107	0.00194	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00105	0.00191	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00103	0.00187	CcSEcCtD
Phentolamine—Pain—Doxorubicin—testicular cancer	0.00102	0.00185	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—testicular cancer	0.00102	0.00185	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—testicular cancer	0.000988	0.00179	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000975	0.00177	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—testicular cancer	0.000974	0.00177	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—testicular cancer	0.000942	0.00171	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—testicular cancer	0.000942	0.00171	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—testicular cancer	0.000924	0.00168	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—testicular cancer	0.000911	0.00166	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—testicular cancer	0.00091	0.00165	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—testicular cancer	0.000881	0.0016	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—testicular cancer	0.000875	0.00159	CcSEcCtD
Phentolamine—Headache—Methotrexate—testicular cancer	0.000862	0.00157	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—testicular cancer	0.000855	0.00155	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—testicular cancer	0.000852	0.00155	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—testicular cancer	0.000843	0.00153	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—testicular cancer	0.000819	0.00149	CcSEcCtD
Phentolamine—Nausea—Methotrexate—testicular cancer	0.000818	0.00149	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—testicular cancer	0.000816	0.00148	CcSEcCtD
Phentolamine—Headache—Epirubicin—testicular cancer	0.000807	0.00147	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—testicular cancer	0.000788	0.00143	CcSEcCtD
Phentolamine—Nausea—Epirubicin—testicular cancer	0.000765	0.00139	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—testicular cancer	0.000758	0.00138	CcSEcCtD
Phentolamine—Headache—Doxorubicin—testicular cancer	0.000747	0.00136	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—testicular cancer	0.000708	0.00129	CcSEcCtD
